Innovative Treatment Achieves 82% Success in Bladder Cancer Cure
TL;DR
A new implant called TAR-200 has shown promising results in a phase 2 trial, eliminating tumors in 82% of high-risk bladder cancer patients resistant to previous treatments, with most tumors disappearing within three months and many patients remaining cancer-free after a year, offering a potentially safer and more effective alternative to traditional therapies.
- Tiny implant wipes out bladder cancer in 82% of patients ScienceDaily
- Some cancer patients could avoid surgery with innovative new therapy Fox News
- ��Most Effective Therapy to Date” – New Treatment Wipes Out Bladder Cancer in 82% of Patients SciTechDaily
- "Our goal is a solution for every bladder cancer patient" Johnson & Johnson
- Urologist describes early experience with gemcitabine intravesical system in NMIBC Urology Times
Want the full story? Read the original reporting
Read on ScienceDaily